Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

This study has been terminated.
(Study stopped 12/2010 due to poor enrollment. Only 15 of 60 needed enrolled.)
Sponsor:
Collaborators:
University of Chicago
University of Illinois at Chicago
Ruth M. Rothstein CORE Center
Abbott
Gilead Sciences
Information provided by (Responsible Party):
Allan Tenorio, MD, Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT00775606
First received: October 17, 2008
Last updated: May 28, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)